以乳头溢血为唯一临床表现的乳腺癌一例

doi:10.3969/j.issn.1009-976X.2022.06.013

岭南现代临床外科 ›› 2022, Vol. 22 ›› Issue (06): 592-594.DOI: 10.3969/j.issn.1009-976X.2022.06.013

以乳头溢血为唯一临床表现的乳腺癌一例

王永南¹, 严珊珊²

广东省妇幼保健院 1.乳腺科; 2.病理科,广州 511400

通讯作者: * 王永南,Email：3083453838@qq.com
基金资助:
广东省医学科研基金立项课题（A2021063）

A case of breast cancer with nipple hemorrhage as the only clinical manifestation

WANG Yong-nan¹, YAN shan-shan²

1. Department of Breast Diseases, Women and Children Hospital of Guangdong, Guangzhou 511400, China;
2. Department of Pathology, Women and Children Hospital of Guangdong, Guangzhou 511400, China

Received:2022-04-08 Online:2022-12-20 Published:2023-02-03
Contact: WANG Yong-nan, 3083453838@qq.com

摘要/Abstract

摘要： 收治一例以乳头溢血为唯一临床表现的乳腺癌,术前通过完善乳腺X线检查、乳腺超声、乳腺导管内镜及乳腺MRI等检查后,择期行右乳病变乳管切除活检术,术中冰冻病理提示乳腺癌,最终成功行右乳癌保乳术。对于伴有病理性乳头溢液的乳腺癌,即使乳腺超声和乳腺X线摄片检查均为阴性,应继续完善乳管镜和乳腺MRI检查避免漏诊;乳头乳晕复合体无受累及病变范围比较局限的患者,保乳手术也是可选的手术方式。

关键词: 乳腺癌, 乳头溢血, 手术

Abstract: A case of breast cancer with nipple hemorrhage as the only clinical manifestation has been treated. After preoperative mammography, breast ultrasound, duct endoscopy, and MRI examinations, selective duct excision were performed. Frozen suggested breast cancer, and finally successful breast-conserving surgery was performed. For breast cancer with pathologic nipple discharge （PND）, even if breast ultrasound and mammography are negative, ductoscopy and MRI should be continued to avoid missed diagnosis. Breast-conserving surgery is also an option for patients with no nipple-areola complex （NAC） involvement and limited lesions.

Key words: breast cancer, nipple hemorrhage, surgery

中图分类号:

R737.9

王永南, 严珊珊. 以乳头溢血为唯一临床表现的乳腺癌一例[J]. 岭南现代临床外科, 2022, 22(06): 592-594.

WANG Yong-nan, YAN shan-shan. A case of breast cancer with nipple hemorrhage as the only clinical manifestation[J]. Lingnan Modern Clinics In Surgery, 2022, 22(06): 592-594.

参考文献

[1] 杨阳,王殊,佟富中,等. 乳腺MRI在病理性乳头溢液诊断中的价值[J]. 中华普通外科杂志, 2021, 36(8): 575-578.
[2] Zhang C, Li J, Jiang H, et al.Use of fiberoductoscopy for the management of pathological nipple discharge: ten years follow up of a single center in China[J]. Gland Surg, 2020, 9(6): 2035-2043.
[3] Wong Chung JE, Jeuriens-van de Ven SA, van Helmond N, et al. Does Nipple Discharge Color Predict (pre-) Malignant Breast Pathology?[J]. Breast J,2016,22(2):202-208.
[4] Clark SE, Agrawal A, Laws S, et al.The investigation and management of unilateral nipple discharge[J]. Ann R Coll Surg Engl,2020,102(5):369-374.
[5] Al Nemer A, Kussaibi H.The accuracy of nipple discharge cytology in detecting breast cancer[J]. Diagnosis (Berl), 2020,8(2):269-273.
[6] Weaver M, Stuckey A.Benign Breast Disorders[J]. Obstet Gynecol Clin North Am,2022,49(1):57-72.
[7] Expert Panel on Breast Imaging: Lee SJ, Trikha S, et al. ACR Appropriateness Criteria? Evaluation of Nipple Discharge[J]. J Am Coll Radiol,2017,14(5S):S138-S153.
[8] Zacharioudakis K, Kontoulis T, Vella JX, et al.Can we see what is invisible? The role of MRI in the evaluation and management of patients with pathological nipple discharge[J]. Breast Cancer Res Treat, 2019,178(1):115-120.
[9] Waaijer L, Simons JM, BorelRinkes IH, et al. Systematic review and meta-analysis of the diagnostic accuracy of ductoscopy in patients with pathological nipple discharge[J]. Br J Surg, 2016,103(6):632-643.
[10] Montroni I, Santini D, Zucchini G, et al.Nipple discharge: is its significance as a risk factor for breast cancer fully understood? Observational study including 915 consecutive patients who underwent selective duct excision[J]. Breast Cancer Res Treat, 2010,123(3):895-900.
[11] Dent BL,Miller JA, Eden DJ, et al.Tumor-to-Nipple distance as a predictor of nipple involvement: expanding the inclusion criteria for Nipple-Sparing mastectomy[J]. Plast Reconstr Surg,2017,140: 1e-8.
[12] 刘丽,池月芮. 早期乳腺癌影像学检查现状与展望[J]. 岭南现代临床外科,2019, 19(5):623-627.
[13] Hill MV, Beeman JL, Jhala K, et al.Relationship of breast MRI to recurrence rates in patients undergoing breast-conservation treatment[J]. Breast Cancer Res Treat, 2017,163(3):615-622.
[14] Chang RY, Cheung PS.Nipple Preservation in Breast Cancer Associated with Nipple Discharge[J]. World J Surg,2017,41(1):176-183.
[15] Lago V, Maisto V, Gimenez-Climent J, et al.Nipple-sparing mastectomy as treatment for patients with ductal carcinoma in situ: A 10-year follow-up study[J]. Breast J,2018,24(3):298-303.

以乳头溢血为唯一临床表现的乳腺癌一例

A case of breast cancer with nipple hemorrhage as the only clinical manifestation

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	姚欣逸, 徐宝红, 张孟婷, 黄泳欣. FOXA1通过调控XBP1的转录促进乳腺癌增殖的功能及机制研究[J]. 岭南现代临床外科, 2023, 23(1): 10-18.
[2]	申美莹, 潘华文, 赵丽, 胡波涛, 徐波, 韦伟, 崔军威. 乙酰脱氢酶1在乳腺癌前哨淋巴结中的表达及临床意义[J]. 岭南现代临床外科, 2023, 23(1): 19-25.
[3]	周小波. 腹腔镜胰十二指肠切除术的手术入路的研究进展[J]. 岭南现代临床外科, 2023, 23(1): 84-87.
[4]	王尊, 朱烨丰, 李璐, 姜敏, 高迎飞, 符式新. 动态增强MRI在乳头乳晕复合体血供特征评估中的应用[J]. 岭南现代临床外科, 2022, 22(06): 537-541.
[5]	姚公志, 姜惠悦, 林家丽, 孙璐. 纯净波线阵探头在早期乳腺癌诊断和保乳切除术前肿块切缘定位的应用价值[J]. 岭南现代临床外科, 2022, 22(06): 542-546.
[6]	强勇嘉, 曾宽, 刘竹轩, 许浩华, 杨艳旗. 胸腔镜辅助下二尖瓣手术的临床观察[J]. 岭南现代临床外科, 2022, 22(06): 560-564.
[7]	廖小慧, 杨长青, 魏子白. 肝硬化中的血小板变化机制及影响[J]. 岭南现代临床外科, 2022, 22(06): 600-605.
[8]	陈玩娜, 梁小立, 张展强, 徐荷洋, 林勃, 张兆禧, 禹菊, 郑亮, 黄津耀, 张景, 陆漪琳, 黄佳泳, 李瑞霞, 李杰, 吕伟明. 乳腺癌辅助化疗后预防性使用乙二醇化重组人粒细胞刺激因子的成本效果分析和对生活质量的影响[J]. 岭南现代临床外科, 2022, 22(05): 451-457.
[9]	蔡上林, 王博, 李坚. 吲哚菁绿荧光显影导航技术在肝胆外科手术中的应用进展[J]. 岭南现代临床外科, 2022, 22(04): 315-321.
[10]	张桥, 莫阿里, 高恒毅, 周伟, 夏丰, 张伟桥, 陈伟强. 直径不大于5 cm孤立性肝癌：射频消融与手术治疗的比较[J]. 岭南现代临床外科, 2022, 22(04): 328-335.
[11]	周婕, 左艳玲, 王倩, 姜明, 吴丹丹, 李洪胜. 超声引导下真空辅助切除手术对乳腺导管内乳头状瘤的诊断和治疗价值[J]. 岭南现代临床外科, 2022, 22(04): 354-357.
[12]	陈景森, 张文夏, 李欢, 熊志毅, 王恩礼. 全数字钼靶提高同时性双侧乳腺癌检出率的临床研究[J]. 岭南现代临床外科, 2022, 22(03): 223-226.
[13]	孔德海, 冯德香, 赵永杰, 关国锋, 尹刚. 双反牵引在Pilon骨折围手术期的应用研究[J]. 岭南现代临床外科, 2022, 22(03): 245-249.
[14]	潘佳仁, 潘华锋, 王平. 腹腔镜肾癌根治术后切口感染的手术室相关因素分析及术前NLR、PLR的意义[J]. 岭南现代临床外科, 2022, 22(03): 272-275.
[15]	李逸林, 韩玮, 施郦媛, 陈绪, 王旸, 王康, 鲁凯. 浆细胞性乳腺炎并发导管原位癌一例报告[J]. 岭南现代临床外科, 2022, 22(03): 302-305.